Reuters logo
BRIEF-Intellia Therapeutics, Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes
April 26, 2017 / 11:45 AM / 8 months ago

BRIEF-Intellia Therapeutics, Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes

April 26 (Reuters) - Crispr Therapeutics AG

* Intellia Therapeutics and Crispr Therapeutics announce U.S. patent covering crispr/cas9 ribonucleoprotein complexes

* Crispr Therapeutics - United States patent and trademarks office is expected to issue a crispr/cas9 genome editing patent to Vilnius University

* Patent is expected to issue on May 2, 2017 as U.S. patent no. 9,637,739 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below